NCT04122196View on ClinicalTrials.gov

Perioperative Pregabalin in Ureteroscopy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2024

Conditions
Kidney StonePain, PostoperativeAddictionOpioid Use
Interventions
DRUG

Pregabalin 300mg

Patient will receive a compounded version of 300mg pregabalin PO approximately one hour before surgery.

DRUG

Placebo oral tablet

Patient will receive a compounded version of inactive placebo PO approximately one hour before surgery.

Trial Locations (1)

65212

University of Missouri-Columbia, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT04122196 - Perioperative Pregabalin in Ureteroscopy | Biotech Hunter | Biotech Hunter